Appendix A: Key to Acronyms
This section has information on Appendix A: Key to Acronyms. Please click on the below links or follow the table of contents to access the information you are looking for. Study and Trial Names General Terms Drug Name Abbreviations
Appendix B: Drug Characteristics Table
DHHS Last Updated: September 2024Australian Commentary Last Updated: December 2024 LINKS TO TABLES HERE AU Commentary: Table 1 Coformulated and Copackaged Antiretroviral Regimens Stribild – this product has been removed from the market in Australia, access to generic equivalents are NOT available. Atripla – this product has been removed from the market in Australia, access to generic equivalent is […]
Committee
ASHM Sub-Committee for Guidance on HIV Management The Australian Commentary has been written and reviewed by members of the ASHM Sub-Committee for Guidance on HIV Management in Australia. The members of the Sub-Committee are listed below: Name Affiliation Position Rick Varma Chair appointed by ASHM Board Senior Staff Specialist (Sexual Health) and Clinical Services Manager, Sydney […]
Financial Disclosure
Name Entity Relationship Benefit to Individual Benefit to Institution Rick Varma (chair) None N/A Andrew Grulich Seqirus Grant/grants pending X Cancer Council NSW Grant/grants pending X American Foundation for AIDS Research Grant/grants pending X Gilead Educational presentations X Merck Educational presentations X NHMRC Travel expenses X Cure […]